UMIN ID: UMIN000018104
Registered date:26/06/2015
Withdrawal and Dose Reduction of Pioglitazone in Patients with Type 2 Diabetes: A Chart-Based Analysis
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Type 2 diabetes |
Date of first enrollment | 2014/09/01 |
Target sample size | 71 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | The change of body weight, plasma glucose, HbA1c, HDL, LDL, TG, AST, ALT after the dose reduction and withdrawal of pioglitazone |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 100years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Type 1 diabetes Secondary diabetes |
Related Information
Primary Sponsor | National Center for Global Health and Medicine Kohnodai Hospital |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | none |
Secondary ID(s) |
Contact
public contact | |
Name | Hisayuki Katsuyama |
Address | 1-7-1 Kohnodai, Ichikawa, Chiba, 272-0034, Japan |
Telephone | +81-47-272-0034 |
katsuyama-hs@umin.org | |
Affiliation | National Center for Global Health and Medicine Kohnodai Hospital Department of Internal Medicine |
scientific contact | |
Name | Hisayuki Katsuyama |
Address | 1-7-1 Kohnodai, Ichikawa, Chiba, 272-0034, Japan |
Telephone | +81-47-272-0034 |
katsuyama-hs@umin.org | |
Affiliation | National Center for Global Health and Medicine Kohnodai Hospital Department of Internal Medicine |